This study found that the expression of RMI2 was related to TME, immune infiltration, and ICPs of pan-cancer, but there are no in vivo or in vitro experiments directly proved that RMI2 affects the survival of tumor patients through these immunological mechanisms. This evidence concerns the gene RMI2 and neoplasm.